| Summary of Restatement of Balance Sheet |
The effect of the adjustments on the line items on the Company’s consolidated balance sheet as of December 31, 2020 was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
$ |
30,292 |
|
|
$ |
(4,841 |
) |
|
$ |
25,451 |
|
|
|
|
50,464 |
|
|
|
(4,841 |
) |
|
|
45,623 |
|
|
|
|
357,974 |
|
|
|
(4,841 |
) |
|
|
353,133 |
|
Accrued and other current liabilities |
|
|
56,381 |
|
|
|
(1,328 |
) |
|
|
55,053 |
|
|
|
|
233,207 |
|
|
|
(1,328 |
) |
|
|
231,879 |
|
|
|
|
307,132 |
|
|
|
(1,328 |
) |
|
|
305,804 |
|
|
|
|
(720,629 |
) |
|
|
(3,513 |
) |
|
|
(724,142 |
) |
Total shareholders’ equity |
|
|
50,842 |
|
|
|
(3,513 |
) |
|
|
47,329 |
|
Total liabilities and shareholders’ equity |
|
|
357,974 |
|
|
|
(4,841 |
) |
|
|
353,133 |
|
|
| Summary of Restatement of Statement of Operations |
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
For the Nine Months Ended September 30, 2020 |
|
| |
|
|
|
|
|
|
|
|
|
Costs and expenses applicable to revenues |
|
$ |
(40,789 |
) |
|
$ |
(5,454 |
) |
|
$ |
(46,243 |
) |
|
|
|
64,899 |
|
|
|
(5,454 |
) |
|
|
59,445 |
|
|
|
|
(234,192 |
) |
|
|
(5,454 |
) |
|
|
(239,646 |
) |
Loss from operations before income tax 1
|
|
|
(269,051 |
) |
|
|
(5,314 |
) |
|
|
(274,365 |
) |
|
|
|
13,680 |
|
|
|
(1,408 |
) |
|
|
12,272 |
|
|
|
|
(282,591 |
) |
|
|
(4,046 |
) |
|
|
(286,637 |
) |
| (1) |
The revised balance includes income of $0.1 million, resulting from a reclassification from the income on equity-accounted investment line to the other income line, on the unaudited interim condensed consolidated statements of operations for the nine months ended September 30, 2020. |
|